Clinical Trial Update: Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes [Phase 4]

View source ↗

Summary

The Phase 4 trial compares pioglitazone with insulin glargine for patients with type 2 diabetes experiencing secondary drug failure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Skane University Hospital | Conditions: Type 2 Diabetes, Secondary Drug Failure | Phase 4 | Status: COMPLETED